A7 - Limited Source Justification (000HCUGD-2020-45039) - Orbitrap Eclipse.pdf
PDF 3 MB Posted
- Attached to
- Orbitrap Eclipse Mass Spectrometer
- Solicitation number
- 000HCUGD-2020-45039
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Equipment List.pdf |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Please wait...
If this message is not eventually replaced by the proper contents of the document, your PDF viewer may not be able to display this type of document.
You can upgrade to the latest version of Adobe Reader for Windows®, Mac, or Linux® by visiting http://www.adobe.com/go/reader_download.
For more assistance with Adobe Reader visit http://www.adobe.com/go/acrreader.
Windows is either a registered trademark or a trademark of Microsoft Corporation in the United States and/or other countries. Mac is a trademark of Apple Inc., registered in the United States and other countries. Linux is the registered trademark of Linus Torvalds in the U.S. and other countries.
Template for a Federal Supply Schedule (FSS) Limited-Sources Justification
Completion Instructions: HHS has established a standard template for the preparation of a Limited-Sources Justification (LSJ) pursuant to FAR Subpart 8.4. This template is for use with orders issued under the Federal Supply Schedule (FSS) program where the value exceeds simplified acquisition threshold and competition is restricted: (1) to fewer schedule contractors than required in FAR 8.405-1, 8.405-2, or 8.405-3, or (2) to an item peculiar to one manufacturer. See FAR Subpart 8.4 for additional guidance. This template is not for use with acquisitions other than those under FAR Subpart 8.4.
Tailor all aspects of this template to the individual acquisition. Consult FAR 8.405-6 for guidance. An addendum may be added in case additional space is needed.
When this document is printed, the blue italic instructions are automatically deleted on the printed version.
FEDERAL SUPPLY SCHEDULE
LIMITED-SOURCES JUSTIFICATION
2. Description of Action:
Nature:
Pricing:
Funds:
<For each proposed contractor if more than one (e.g., brand name):>
3. Description of Supplies and Services to Include Contract Vehicle/Number Utilized:
Briefly describe the supplies or services to be provided, including make & model number where appropriate. Indicate whether the item to be procured is peculiar to one manufacturer (e.g., a particular brand name, product, or a feature of a product, peculiar to one manufacturer). If applicable, include quantities of supplies or period of performance for services. Provide information for any options included in the order. If the action is a modification to an existing order, distinguish clearly between the work covered by the basic order and the work to be obtained by the proposed modification.
4. Authority:
When competition is limited to items peculiar to one manufacturer, this justification must explain why the particular brand name, product, or feature is essential to the Government's requirements, and that market research indicates other companies' similar products, or products lacking the particular feature, do not meet, or cannot be modified to meet, the agency's needs in accordance with FAR 11.105.
5. Market Research:
Describe the extent of the market research conducted among the schedule holders and the results, or a statement of the reason that market research was not conducted. Brand name specifications shall not be used unless the particular brand name, product, or feature is essential to the Government’s requirements, and market research indicates other companies’ similar products, or products lacking the particular feature, do not meet, or cannot be modified to meet, the agency’s need.
6. Actions to Increase Competition:
Describe the actions, if any, the agency may take to remove or overcome any barriers that led to the restricted consideration prior to any subsequent acquisition for the supplies or services is made. If no such actions have been taken, explain why.
7. Any other facts supporting the justification:
8. Technical / Requirements Certification: By my signature below, I certify that the supporting data under my review which is included in this Limited-Sources Justification is accurate and complete.
Program Manager Name:
Position Title:
Email address:
Phone:
Program Manager Supervisor (or one level above Program Manager) Name:
Position Title:
Email address:
Signature:
Date:
9. Best Value Determination: By my signature below, after review of the relevant documents, I have determined that the order subject to this Limited-Sources Justification represents the best value for the Government as set forth in FAR 8.404(d), and constitutes a fair and reasonable price. The basis for my determination is as follows:
Describe in detail the basis for the determination that this order provides the best value, and that the price is fair and reasonable. Attach and/or summarize applicable market research, commercial prices lists, comparable GSA schedule pricing or other markers that were used in this determination.
10. Contracting Officer's Approval (Required for proposed contract not to exceed $700,000 (value calculated including all options)): I hereby certify that this justification is accurate and complete to the best of my knowledge. I approve this justification subject to the availability of funds, and provided that the services and supplies herein described have otherwise been approved for acquisition.
Name:
Phone:
Signature:
Date:
11. Legal Review:
All J&As greater than $68 million must have a legal review from the General Law Division of the Office of the General Counsel prior to sending it to the Department.
12. OPDIV Competition Advocate Approval (Required for proposed contract over $700,000 but not exceeding $13.5 million (value calculated including all options)):
I have reviewed this justification and find that it adequately supports limiting sources.
Name:
Phone:
Signature:
Date:
13. Office of Small and Disadvantaged Business Utilization:
I have reviewed this justification and find that it adequately supports limiting sources.
Name:
Phone:
Signature:
Date:
14. OPDIV HCA Approval (Required for proposed contract over $13.5 million but not exceeding $68 million (value calculated including all options)):
Name:
Phone:
Signature:
Date:
15. Department Competition Advocate:
Concur:
Non-Concur:
Name:
Phone:
Signature:
Date:
(The below approval paragraph is required if the cumulative contract value, including all options, exceeds $68 million.)
16. HHS Senior Procurement Executive (SPE) Approval:
Based on the foregoing justification, I hereby approve limiting sources for the above stated procurement, subject to the availability of funds, and provided that the services herein described have otherwise been authorized for acquisition.
State supplies/services being procured:
State the full statutory authority and FAR cite and title, consistent with paragraph 4, e.g. 41 U.S.C. 3304:
State the full statutory authority and FAR cite and title, consistent with paragraph 4, e.g. 41 U.S.C. 3304 Name:
Phone:
Signature:
Date:
11.0.0.20130303.1.892433.887364 Justification & Approval - Federal Supply Schedule Health and Human Services Justification & Approval - Federal Supply Schedule
| AcquisitionTitle: Purchase of Orbitrap Eclipse Mass Spectrometer |
| Agency: CDC |
| PSCDrop: |
| NIHDrop: |
| PSCOther: |
| AcqusitionYear: 2020 |
| Author: Suzanne R. Kalb |
| CheckBox4: 1 |
| CheckBox5: 0 |
| CheckBox1: 0 |
| Order/Contract Number:: |
| CheckBox8: 1 |
| CheckBox7: 0 |
| CheckBox6: 0 |
| CheckBox9: 0 |
| Other Pricing: |
| CheckBox10: 0 |
| CheckBox11: 1 |
| Funding amount: |
| TextField5: Thermo Fisher Scientific LLC |
| TextField5: 1400 Northpoint Pkwy Ste 50 |
| TextField5: West Palm Beach, FL 33407-1976 |
| Button2: |
| Button1: |
| 3. Description of Supplies or Services:: Orbitrap Eclipse Mass Spectrometer and Orbitrap ID-X, IC Mass Spectrometer |
FSS#: GS-24F-0026L
| TextField7: 1,847,272.13 |
| State the full statutory authority and FAR cite and title, consistent with paragraph 4, e.g. 41 U.S.C. 3304: Our Toxins and Flu laboratories require advanced proteomics measurements to improve influenza vaccine efficacy, to perform antibiotic susceptibility testing, and to determine the structure of proteins in order to prevent infectious diseases. Our laboratory needs to have the capability to elucidate the structure of proteins in various conformations via the use of covalent labeling of amino acids or chemical crosslinking. Also, we need to be able to identify all modifications such as glycosylation present in a protein; even modifications that are not predicated based on the reagent's chemical specificity. Proteins can mutate, and these amino acid mutations often are of biological interest. Comprehensive characterization of these protein structures requires the ability to perform complete amino acid sequencing of these proteins. This is called de novo sequencing, and this requires an extremely high resolution in both MS and MS/MS modes as well as high accuracy. These measurements must be made in complex biological matrices where the analyte of interest in often present at very low levels. These are very diverse capabilities for a single instrument, so we require a single instrument which consists of two independent mass spectrometers which can perform separately and simultaneously as well as together, so that we can perform high resolution accurate mass measurements simultaneously with MS/MS structural analyses. A mass spectrometer that has all of the characteristics required for this work is a quadrupole Orbitrap liner ion trap hybrid, the Orbitrap Eclipse. Therefore, we require the purchase of one Orbitrap Eclipse mass spectrometer system. This system has a sole manufacturer, and a sole vendor: Thermo Fisher Scientific. |
| State the full statutory authority and FAR cite and title, consistent with paragraph 4, e.g. 41 U.S.C. 3304: GS-24F-0026L |
The requested Thermo Fisher Scientific Orbitrap Eclipse Mass Spectrometer offers the flowing unique capabilities that no other vendor can supply as Thermo Fisher Scientific is the sole manufacturer and sole vendor of the equipment:
1. Ten stages of MS/MS analysis (MS10) for the greatest amount of protein sequence coverage and to more accurately pinpoint crosslinking, covalent labeling, and glycosylation sites.
2. A variety of MS/MS modes including CID, HCD, ETD, and EThcD at any of the 10 MS/MS stages for accurate information.
3. Capability to perform both positive ion and negative ion ETD.
4. Mass resolution greater than 500,000 FWHM resolving power at m/z 200.
5. Mass range of high-resolution mass analyzer of 8000 m/z.
6. Scan speeds of high-resolution mass analyzer up to 40 Hz at 7,500 FWHM.
7. QR5 segmented quadrupole with 0.4 m/z precursor isolation width.
8. Real-time search capabilities to use with mass tags for quantitative proteomic analysis.
9. Ion routing multipole capable of performing HCD at any MSn stage.
10. Xcalibur software offering seamless integration with a wide variety of vendors' HPLC systems.
11. Vendor trained On-site service and support available in our lab.
| CheckBox12: 1 |
| CheckBox13: 0 |
| CheckBox13: 0 |
| CheckBox13: 0 |
| CheckBox13: 1 |
| Describe in detail the basis for the determination that this order providers the best value, and that the price is fair and reasonable. Attach and/or summarize applicable market research, commercial prices lists, comparable GSA schedule pricing or other markers that were used in this determination.: Several market research techniques were used to identify other possible sources as listed in detail in a separate market research document, including review of market research on similar items, queries of internet information sources, contact of knowledgeable individuals in the government and in industry, and review of catalogs and product literature. Market research determined that the only equipment which would meet our needs is the Orbitrap Fusion Lumos mass spectrometer, and Thermo Fisher Scientific is the sole manufacturer and vendor of this equipment. |
| Describe in detail the basis for the determination that this order providers the best value, and that the price is fair and reasonable. Attach and/or summarize applicable market research, commercial prices lists, comparable GSA schedule pricing or other markers that were used in this determination.: Market research was performed to search for alternatives. Market research determined that no other alternatives existed. |
| Describe in detail the basis for the determination that this order providers the best value, and that the price is fair and reasonable. Attach and/or summarize applicable market research, commercial prices lists, comparable GSA schedule pricing or other markers that were used in this determination.: Price analysis will be used to determine the price to be fair and reasonable. Pricing will be at or below established GSA Schedule pricing. |
| Program Manager name: Suzanne R. Kalb |
| Program Manager position title: Research Chemist/COR II |
| Program Manager email address: skalb@cdc.gov |
| Program manager phone number: 770-488-7931 |
| Program Manager Supervisor name: John R. Barr |
| Program Manager Supervisor Position title: Chief, Clinical Chemistry Branch |
| Program Manager Supervisor email address: jbarr@cdc.gov |
| HHS Senior Procurement Executive (SPE) signature: |
| Program Manager Supervisor date: February 10, 2020 |
| filepath: |
| Contract Officer's Approval name: H. Dale Bish |
| HHS Senior Procurement Executive (SPE) phone: 404-498-1312 |
| HHS Senior Procurement Executive (SPE) phone: 404-639-7291 |
| HHS Senior Procurement Executive (SPE) phone: 770-488-2628 |
| Contract Officer's Approval date: 2020-05-07 |
| HHS Senior Procurement Executive (SPE) name: Sherry Smallwood |
| HHS Senior Procurement Executive (SPE) name: Jeffrey L. Napier, Dir OAS, HCA |
| DateField6: 2020-06-09 |
| Office of Small Business date: |
| OPDIV HCA date: 2020-05-29 |
| Concur with Acquisition: 0 |
| Non-Concur with Acquisition: 0 |
| HHS Senior Procurement Executive (SPE) date: |
| State supplies/services being procured: |
File details come from the government source that posted it. Updated .